Advertisement

U.S. Markets open in 8 hrs 24 mins

S&P Futures
4,020.50
+19.00(+0.47%)
Dow Futures
32,712.00
+124.00(+0.38%)
Nasdaq Futures
12,785.25
+52.75(+0.41%)
Russell 2000 Futures
1,776.50
+11.70(+0.66%)
Crude Oil
73.59
+0.39(+0.53%)
Gold
1,967.50
-6.00(-0.30%)

Advertisement

NexgenRx Inc. (NEGXF)

Other OTC - Other OTC Delayed Price. Currency in USD

0.2021

0.0000

(0.00%)

At close: 04:30PM EDT

Advertisement

Trade prices are not sourced from all markets

Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies

Neutralpattern detected

All

Simply Wall St.
Is NexgenRx Inc.'s (CVE:NXG) Recent Stock Performance Tethered To Its Strong Fundamentals?
NexgenRx's (CVE:NXG) stock is up by a considerable 30% over the past three months. Since the market usually pay for a...
Simply Wall St.
If EPS Growth Is Important To You, NexgenRx (CVE:NXG) Presents An Opportunity
The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...
ACCESSWIRE
NexgenRx Announces Q3 2022 Financial Results with Continued Revenue Growth, Positive EBITDA and Free Cash Flow
NEXGENRX INC.("NexgenRx" or the "Company") is pleased to announce its interim financial results for the third quarter ended September 30, 2022, highlighted by continued revenue growth, positive EBIDTA and increased free cash flow. During Q3 2022, the Company showed revenue growth of 15.81% over the same period last year. Revenue for the third quarter was $3,317,358 and $9,401,460 year-to-date.

Advertisement